ReviewAnnals of dermatology2026
Photoaging: Update on Pathogenesis, Prevention, and Treatment.
Review in Annals of dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skin aging is driven by the intrinsic aging process, onto which extrinsic environmental stimuli exert damaging effects. Amongst the external factors, chronic sun exposure contributes the most, and that effect is recognized as photoaging. Clinically, photoaged skin commonly presents with wrinkles and pigmentary changes. Since the first report on the improvement of photoaged skin by topical tretinoin, subsequent investigations have significantly expanded our understanding of this phenomenon. In this narrative review, we adopt a mechanism-driven perspective to discuss the development, manifestations, and treatments for photoaging. We describe the traditional paradigm of ultraviolet radiation-induced extracellular matrix degradation, as well as additional signaling pathways and molecular players that have since been discovered, such as the roles of aryl hydrocarbon receptor, matrix metalloproteinase-2, and nuclear factor erythroid 2-related factor signaling. We describe features of photoaging across skin types, including the increased susceptibility to developing pigmentary alterations in skin of color, along with the role of photoprotection in preventing them. Finally, we review the mechanism and efficacy of common topical, oral, and office-based treatments for photoaging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.